Loading...
•
Mar 31, 2024
TherapeuticsMD Q1 2024 Earnings Report
Reported financial results for the first quarter ended March 31, 2024.
Key Takeaways
TherapeuticsMD, Inc. reported financial results for the first quarter ended March 31, 2024, focusing on pharmaceutical royalties collection after transitioning from a women's healthcare company in December 2022.
TherapeuticsMD is now primarily focused on collecting royalties from its licensees.
The company is no longer engaged in research and development or commercial operations.
TherapeuticsMD is evaluating strategic alternatives, including potential acquisition, merger, or sale of assets.
The company's future performance depends on the success of its licensees in commercializing licensed products.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...